Sadly, there are still 791 days until the next presidential inauguration.

Welcome…

November 17th, 2026|

Harry Stevens writes on data centers in the NY Times; an excerpt:

“The largest data centers in the United States are responsible for an estimated 25.7 million metric tons of carbon dioxide emissions annually — almost as much as entire countries like Bolivia or Denmark — according to new research.

The study, published Monday in the journal Nature Sustainability, delivers the first peer-reviewed estimates of carbon dioxide emissions from the country’s biggest data centers since the start of the artificial intelligence boom. Its authors, a team led by researchers from Harvard University, examined the electricity consumption and carbon emissions of 403 data centers from May 2024 to April 2025.

All told, those data centers used almost 2 percent of U.S. electricity, more than New York City and Los Angeles combined, and represented about 0.5 percent of U.S. carbon dioxide emissions. Carbon dioxide is the primary greenhouse gas driving global warming.”

May Brownstein has more detail in the Harvard Gazette.

November 4th, 2026|

Recommended:

Put in the sad but probably true category Matt Yglesias’ Slow Boring comments on the steadfast resolution of our US Senators:

“The problem is that senators really love their precious filibuster because it lets them not vote on stuff…I was saying to a friend who works on the Hill that senators should practice in the mirror saying, “I hear what you’re saying and I respect you but I’m not going to vote for that because I think it’s a bad idea.” He told me they are nowhere near the headspace of embracing that. They love to be able to sign on to bills that can’t possibly pass and then reassure people who don’t like the bill that it can’t possibly pass. Or else to tell proponents of some bill that they’d love to do X, Y, and Z but it’s just not possible given the filibuster. I think this dynamic of constant lying and ducking of responsibility is bad for democracy, but I’m not a senator.”

Jamelle Bouie, writing in the NY Times on the filibuster:

“The American people elected Democrats to hold Trump accountable for corruption and despotism, and to govern. Congressional Democrats can do the former of their own accord. But to have any hope for the latter, Senate Democrats need to end, or at least amend, the filibuster. Anything less would squander the opportunity they’ve been given by voters…For most of its history, the Senate operated by simple majority vote. The filibuster was used only in extraordinary circumstances…a Congress that is passing legislation at a regular pace is a Congress that looks productive to voters who want their government to be doing something.

The only way to do this is to cast the filibuster aside. If that is too much, if Senate Democrats want to preserve the tradition of unlimited debate, then Democrats could instead reform the filibuster to require 41 members on the floor to continue debate, rather than 60 members to end it. In other words, they could put the burden on the party that wants to obstruct or halt the process, not on the one that wants to work.”

• Kristen Panthagani points out RFK Jr’s rank hypocrisy in her You Can Know Things blog. Excerpts:

“In June 2025, RFK Jr. wrote an op-ed in the Wall Street Journal announcing his decision to fire all 17 members of the CDC’s vaccine advisory panel (ACIP). His main criticism? “The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine,” he falsely claimed.”

and after Kennedy became HHS Secretary, he proclaimed:

“The panelists — in HHS, in FDA, CDC, and NIH, there are panels that are made up of outside individuals, outside experts, who come and set policies. They set, for example, […] the food pyramid, the nutrition guidelines, the vaccine guidelines, the medical standards of care. In the past those people, almost all of them, have severe, severe conflicts of interest.”

And now? The previous FDA panel banned compounding of peptides due to safety concerns, but

“…the new FDA panel voted to reverse that decision. That panel included new members appointed under RFK Jr.’s leadership — many of whom have direct ties to the peptide industry: a CMO of a wellness company that sells peptides, the founder of a company that provides “premier advisory in peptide therapy,” and the founder of a wellness company that provides custom protocols including peptide therapy, just to name a few (more are listed here.)”

and

“A New York Times investigation found that four of the eight new members appointed by RFK Jr. own stock in pharmaceutical companies that will likely be influenced by their decisions on the task force. Stocks were described in conflict-of-interest waivers granted to these members, and include stock ownership in Eli Lilly, Johnson & Johnson, Merck, Pfizer, Cigna, CVS Health, and others. Before RFK Jr., candidates would have been asked to sell these stocks rather than being granted waivers. And if they refused, they would not have been granted a position on the task force.”